FDANonrulemakingFDA-2008-D-0525
Who commented on this docket
Draft Guidance for Industry on “New Contrast Indication Considerations for Devices and Approved Drug and Biological Products”; Availability
2 organizations filed 2 public comments on Draft Guidance for Industry on “New Contrast Indication Considerations for Devices and Approved Drug and Biological Products”; Availability, at the Food and Drug Administration. The comment window closed 6413d ago.
Organizations
2
Comments
2
RIN
—
Comment window
closed 6413d ago
Commenters (2)
- Advanced Medical Technology Associationtrade assoc.1 filing · confidence 97%
- Medical Imaging & Technology Alliancetrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.